Remnant cholesterol (RC) is associated with an increased risk of chronic kidney disease (CKD), according to findings from a recent systematic review and meta-analysis.1
In addition to being linked to CKD risk, RC was also associated with progression to end-stage renal disease (ESRD) in patients with type 2 diabetes-related kidney disease.1
“While type 2 diabetes and hypertension continue to be the primary drivers of incident CKD, numerous studies have demonstrated that dyslipidemia—closely associated with these entities—plays a crucial pathogenic role in the development and progression of CKD,” Paschalis Karakasis, MD, MSc, of Aristotle University of Thessaloniki in Greece, and colleagues wrote.1 “Although research to date has predominantly focused on traditional lipid parameters, there is a growing interest…